Not anti-ageing. Pro-living.
Quarterly bloodwork. A UK clinician who reads it as a chapter, not a verdict. A daily protocol that writes the next one.
Choose your subscription
Quarterly billing. Cancel anytime — access continues to the end of the quarter you've paid for.
Founders allocation limited — while stock lasts.
The app
Your biomarker score, your daily protocol, and your wearable data — in one quiet, deliberate place. Built around the Aevique loop: test, analyse, act, retest.
Clinician messaging, trend tracking, and supplement reminders. No noisy gamification. No vanity streaks.
Subscribe to the Aevum tier and we’ll include one NAD+ 1000mg pen with every quarterly billing cycle — four pens a year, a £888 yearly value (£222 per pen). Cold-chain delivery, in-app onboarding, and dose tracking alongside every quarterly panel. While the founders allocation lasts.
Claim Aevum + free NAD+ →Available to all Aevum subscribers — no separate prescription required.
At home or at a partner site, on your schedule.
UK-registered clinicians review every panel before publishing.
Personalised protocol in-app. Optional supplements and Rx consults.
Not ready to subscribe?
Order a single panel — no subscription, no commitment. Same UKAS-accredited lab, same clinician review. Subscribers get 15% off every one-off test.
Browse one-off tests →